Abstract
Electronic health record (EHR) data are a rich and invaluable source of real-world clinical information, enabling detailed insights into patient populations, treatment outcomes, and healthcare practices. The availability of large volumes of EHR data are critical for advancing translational research and developing innovative technologies such as artificial intelligence. The Evolve to Next-Gen Accrual to Clinical Trials (ENACT) network, established in 2015 with funding from the National Center for Advancing Translational Sciences (NCATS), aims to accelerate translational research by democratizing access to EHR data for all Clinical and Translational Science Awards (CTSA) hub investigators. The present ENACT network provides access to structured EHR data, enabling cohort discovery and translational research across the network. However, a substantial amount of critical information is contained in clinical narratives, and natural language processing (NLP) is required for extracting this information to support research. To address this need, the ENACT NLP Working Group was formed to make NLP-derived clinical information accessible and queryable across the network. This article describes the implementation and deployment of NLP infrastructure across ENACT. First, we describe the formation and goals of the Working Group, the practices and logistics involved in implementation and deployment, and the specific NLP tools and technologies utilized. Then, we describe how we extended the ENACT ontology to standardize and query NLP-derived data, as well as how we conducted multisite evaluations of the NLP algorithms. Finally, we reflect on the experience and lessons learnt, which may be useful for other national data networks that are deploying NLP to unlock the potential of clinical text for research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research reported in this publication was supported by the National Institutes of Health under award numbers U01TR002062, UL1TR001998, UM1TR004906, U01TR002628, UL1TR003163, UL1TR001857, U24TR004111, 30TR002103, UL1TR002001, UL1TR002377, and UM1TR004407 from the National Center for Advancing Translational Sciences, award numbers RF1AG072799, R01AG060993, R01AG077017, and R01AG068007 from the National Institute on Aging, award number R01LM014306 from the National Library of Medicine, award number R01GM141476 from the National Institute of General Medical Sciences, and the Reynolds and Reynolds Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by the University of Pittsburgh Institutional Review Board (IRB).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
